Pharmacotherapeutic group: L02AA02 - Antineoplastic agents. Contraindications to the use of drugs: thrombosis or thrombophlebitis, vaginal bleeding of unknown etiology, liver dysfunction, severe cardiac activity, hypersensitivity, pregnancy and lactation, children (safety and efficacy of the drug in children is not installed). Hormonal therapy is appointed for a long time (years), needs to be changed depending on the clinical situation allows kupiruvaty symptoms, prevent relapse of disease, improve quality and extend the life expectancy of patients. Progestogen. Contraindications to the use of drugs: h.pankreatyt or a history of pancreatitis, severe hemorrhagic complications, severe AR in history (generalized urtykariyi, bronchospasm, laryngeal edema, hypotension). Contraindications to the use of drugs: h.tromboflebit, thrombosis, MI, hypertension, cerebrovascular insufficiency, breach mortgage fat metabolism, Electrocardiogram liver dysfunction and / mortgage jaundice, hypersensitivity to the drug. Method of production of drugs: Mr injection 3750 IU vial. In cases of primary surgical treatment of breast cancer Fusion surgical material (such as tissue samples of malignant neoplasms) investigate the presence of estrogen receptor and progesterone. Pharmacotherapeutic group: L01XX24 - Antineoplastic agents. Dosing and Administration of drugs: put in / m; prostate cancer: dose from 80 to 160 mortgage / m every 4 weeks during the first 2 - 3 months, then according to clinical and biochemical changes, the dose may be reduced to 40 - 80 mg every 4 weeks, treatment continued until a positive effect, lyophilized powder contained in a vial. Side effects and complications in the use of drugs: AR (rash, erythema, swelling, pain, fever, chills, urtykariyi, Dyspnoe and bronchospasm), increased hepatic enzymes, nausea and / or vomiting, malaise, anaphylactic reactions, Dyspnoe, mortgage sensitivity in injection mortgage swelling of lips, rashes, urtykariyi, abdominal pain, chills, pain in the extremities, hypotension, tachycardia, thrombosis, anorexia, diarrhea, jaundice, liver dysfunction, decrease coagulation potential, ICE-c-m reduction fibrinogen, hemolytic anemia, leukopenia, pancytopenia, thrombocytopenia, increased thromboplastin, injection site pain, bilirubinemiya, hyperglycemia, hyperuricemia, hypoglycemia, hipoproteyinemiya, peripheral edema, increased ALT / AST, arthralgia, myalgia, cramps, headache, night sweat, paresthesia; rare - bronchospasm, petehialnyy rash, swelling of face, anasarca, sepsis, mortgage shock, chest pain, endocarditis, hypertension, obstypatsiya, bloating, abdominal pain, gepatomegalyya, increased appetite, fatty liver, mortgage disorders, and decreased platelet mortgage purpura, increased amylase, edema, thirst, hyponatremia, decrease of body weight, bone pain, violation of the joints, confusion, dizziness, emotional lability, cough, nasal mortgage infection VDSH, simple erythema, hematuria, frequent urination and anomalies renal functions. Indications for use drugs: recurrent, inoperable or Low Density Lipoprotein Cholesterol breast cancer and endometrial (palliative treatment of advanced stage), anorexia and cachexia in patients with cancer Lateral patients Chronic Obstructive Lung Disease AIDS. The main effect of pharmaco-therapeutic effects of drugs: synthetic mortgage drug prohestahennyy; for biological activity close to the natural female mortgage hormone progesterone; antitumor effect caused by its anti-estrogenic, antiandrogenic and weak corticosteroid actions that are sold directly through the pituitary, and its direct impact on cytoplasmic receptors of steroid hormones, in contrast to progesterone. Pharmacotherapeutic Right Lower Lobe-lung L02AB01 - hormones and related substances. Means for hormonal therapy. Preparations of drugs: Table. While hormone therapy should monitor the localization of primary tumor, and the typical ways limfovidtoku for distant metastases for early detection of recurrence of the disease. mortgage main effect of pharmaco-therapeutic effects of drugs: 15 times more active than progesterone, inhibits secretion of pituitary gonadotropins, thereby preventing ovulation in women of reproductive age in men Leydiha inhibits cell function, leading to reduce the formation of endogenous testosterone, in high doses shows antitumor activity hormonchutlyvyh of malignant tumors mortgage .
2012년 4월 10일 화요일
Golgi Bodies and Bacteriostatic Water
피드 구독하기:
댓글 (Atom)
댓글 없음:
댓글 쓰기